OneDigital Investment Advisors’s AbCellera Biologics ABCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$119K Buy
34,000
+10,000
+42% +$36K ﹤0.01% 1420
2025
Q4
$82.1K Buy
24,000
+13,750
+134% +$61.4K ﹤0.01% 1476
2025
Q3
$51.6K Buy
+10,250
New +$45.2K ﹤0.01% 1474

Other funds holding ABCL

OneDigital Investment Advisors's ABCL Position: Q1 2026 in Review

OneDigital Investment Advisors increased its AbCellera Biologics (ABCL) stake by 42% in Q1 2026, buying an estimated $36K and bringing the position to 34,000 shares worth $119K. The position accounts for ﹤0.01% of the portfolio, ranked #1420.

OneDigital Investment Advisors first reported a position in ABCL in Q3 2025 and has held it in 3 quarters since. 138 funds tracked by Wall St. Rank hold ABCL as of Q1 2026.

  • OneDigital Investment Advisors held 34,000 shares of AbCellera Biologics worth $119K as of Q1 2026.
  • OneDigital Investment Advisors bought 10,000 AbCellera Biologics shares in Q1 2026, an estimated $36K.
  • AbCellera Biologics made up ﹤0.01% of OneDigital Investment Advisors's portfolio in Q1 2026, its #1420 holding.
  • OneDigital Investment Advisors first reported a position in AbCellera Biologics in Q3 2025 and has held it in 3 quarters since.
  • 138 funds tracked by Wall St. Rank held AbCellera Biologics as of Q1 2026.

Based on OneDigital Investment Advisors's 13F filing for Q1 2026, filed 8 May 2026.